Bill Long
Senior Hematology Clinical Account Specialist @Pharmacyclics, An Abbvie Company
Signup · Get unlimited contacts
WORK HISTORY
Senior Hematology Clinical Account Specialist @Pharmacyclics, An Abbvie Company
Ranked #1 Nationally - 2018Ranked #2 Nationally - 2023Launched and Promote Imbruvica -\"1st in Class\" oral BTK inhibitor for - Chronic Lymphocytic Leukemia, Waldenström\'s Macroglobulinemia, Adult and Pediatric cGVHDLaunched and Promote Epkinly - the first and only sub cutaneous, T-cell engaging bispecific antibody for the treatment of adult patients with -** Relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS), including DLBCL arising from indolent lymphoma, and high-grade B–cell lymphoma (HGBL), after two or more lines of systemic therapies.** Relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of systemic therapy. Served as Interim DM during manager transitionServed as first NY/NJ Team Field Based Trainer for 3yrs
EDUCATION
Thomas Edison State University
BA Social Sciences
SKILLS
ABOUT BILL LONG
Hematological Malignancies, Medical Oncology, BM / PBSC Transplant, Hematopathology
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.